Lineage Cell Therapeutics, Inc. (LCTX)

ASE – Real Time Price. Currency in USD

1.11

-0.01 (-1.34%)

Market open: Aug 12, 2026, 12:46 PM EDT

1.13

+0.01 (0.88%)

Previous after-hours: Aug 11, 2026, 7:34 PM EDT

09.08.2026

Lineage Cell Therapeutics Q2 Earnings Call Highlights

Lineage Cell Therapeutics NYSEAMERICAN: LCTX outlined progress across its cell-therapy pipeline during its second-quarter 2026 earnings call, highlighting preclinical advances in corneal disease, Type 1 diabetes and hearing loss programs while Roche and Genentech continue surgical-delivery optimization work for its lead OpRegen program.

07.08.2026

Lineage Cell Therapeutics, Inc. (LCTX) Q2 2026 Earnings Call Transcript

06.08.2026

Lineage Cell (LCTX) Reports Q2 Loss, Lags Revenue Estimates

Lineage Cell (LCTX) came out with a quarterly loss of $0.03 per share in line with the Zacks Consensus Estimate. This compares to a loss of $0.01 per share a year ago.

06.08.2026

Lineage Cell Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update

CARLSBAD, Calif.--(BUSINESS WIRE)---- $LCTX #LineageCellTherapeutics--Q2 2026 Earnings Release.

Videos

No Data

There is no data to display

Press releases

06.08.2026

Lineage Cell Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update

CARLSBAD, Calif.--(BUSINESS WIRE)---- $LCTX #LineageCellTherapeutics--Q2 2026 Earnings Release.

Lineage Cell Therapeutics, Inc. (LCTX)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Lineage Cell Therapeutics, Inc. (LCTX)

Lineage Cell Therapeutics Q2 Earnings Call Highlights

Lineage Cell Therapeutics, Inc. (LCTX) Q2 2026 Earnings Call Transcript

Lineage Cell (LCTX) Reports Q2 Loss, Lags Revenue Estimates

Lineage Cell Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update

Videos

No Data

Press releases

Lineage Cell Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update

Lineage Cell Therapeutics Q2 Earnings Call Highlights

Lineage Cell Therapeutics, Inc. (LCTX) Q2 2026 Earnings Call Transcript

Lineage Cell (LCTX) Reports Q2 Loss, Lags Revenue Estimates

Lineage Cell Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update

Videos

No Data

Press releases

Lineage Cell Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update

Search stocks

Lineage Cell Therapeutics, Inc. (LCTX)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Lineage Cell Therapeutics, Inc. (LCTX)

Lineage Cell Therapeutics Q2 Earnings Call Highlights

Lineage Cell Therapeutics, Inc. (LCTX) Q2 2026 Earnings Call Transcript

Lineage Cell (LCTX) Reports Q2 Loss, Lags Revenue Estimates

Lineage Cell Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update

Videos

No Data

Press releases

Lineage Cell Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update

Lineage Cell Therapeutics Q2 Earnings Call Highlights

Lineage Cell Therapeutics, Inc. (LCTX) Q2 2026 Earnings Call Transcript

Lineage Cell (LCTX) Reports Q2 Loss, Lags Revenue Estimates

Lineage Cell Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update

Videos

No Data

Press releases

Lineage Cell Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update